| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 19.799 | 29.032 | 31.934 | 38.890 | 41.426 | 52.675 | 59.064 | 73.283 | 79.060 |
| Total Income - EUR | - | 19.799 | 29.032 | 31.934 | 38.890 | 41.426 | 52.675 | 70.734 | 73.292 | 79.069 |
| Total Expenses - EUR | - | 3.178 | 6.648 | 13.533 | 14.850 | 22.927 | 26.189 | 37.353 | 36.601 | 55.399 |
| Gross Profit/Loss - EUR | - | 16.622 | 22.384 | 18.401 | 24.040 | 18.500 | 26.486 | 33.382 | 36.691 | 23.671 |
| Net Profit/Loss - EUR | - | 16.027 | 21.855 | 18.082 | 23.651 | 18.119 | 25.959 | 32.674 | 35.958 | 20.677 |
| Employees | - | 0 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Triendogyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 16 | 0 | 0 | 25.624 | 21.198 | 18.411 | 14.051 | 8.415 | 0 |
| Current Assets | - | 16.464 | 38.770 | 55.924 | 25.911 | 17.315 | 24.599 | 61.918 | 101.955 | 120.782 |
| Inventories | - | 414 | 779 | 739 | 1.878 | 3.433 | 4.901 | 7.609 | 7.586 | 0 |
| Receivables | - | 14.688 | 37.127 | 55.175 | 18.912 | 13.446 | 18.034 | 53.556 | 93.548 | 120.222 |
| Cash | - | 1.362 | 865 | 11 | 5.121 | 435 | 1.664 | 754 | 822 | 560 |
| Shareholders Funds | - | 16.072 | 21.899 | 55.046 | 28.893 | 18.160 | 26.000 | 58.755 | 94.534 | 102.119 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 408 | 16.872 | 879 | 22.641 | 20.352 | 17.011 | 17.215 | 15.836 | 18.663 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Triendogyn Srl